Expressão da proteína L1 do capsídio de HPV-16 em leveduras metilotróficas

Molecular exclusion chromatography showed that AFAL has two peaks with an apparent molecular mass of 40 and 80 kDa (Fig. 8 ), suggesting that this lectin undergoes

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical

In the relationship between internet addiction and psychological well-being, the correlation values range from r=-0,104, in the impact on emotions/affections, to r=- 0,201, in the

samples with GFP tagged and higher for the PC and NC that means that the ligands are more specific for the GFP tagged. In another hand, the ratio GFP Mass:Support Mass,

Efficacy of a quadrivalent prophylactic human papillo- mavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions:

Functional expression and purification of bovine enterokinase light chain in recombinant Escherichia coli. Prep

Synthesis of viruslike particles by expression of the putative capsid protein of Leishmania RNA virus in a recombi- nant baculovirus expression system.. A novel virus of the